| Investigator & role |
Grant title |
Funding source |
Duration |
| Scott L. Nyberg principal investigator |
Humanized Spheroid Reservoir Bioartificial Liver
|
Wallace Coulter Award for Biomedical Engineering
|
09/2011 - 08/2014
|
|
Scott L. Nyberg co-investigator
|
Mayo Clinic Center for Cell Signaling in Gastroenterology
|
National Institutes of Health and National Institute of Diabetes and Digestive and Kidney Diseases
|
09/2009 - 08/2014
|
| Scott L. Nyberg principal investigator
|
In Vivo Testing of the Spheroid Reservoir Bioartificial Liver
|
Innovation Loan Program — Mayo Foundation
|
07/2012 - 06/2014
|
| Scott L. Nyberg co-principal investigator
|
Revascularized Decellularized Liver Grafts in a Large Animal Model
|
Innovation Loan Program — Mayo Foundation
|
07/2012 - 06/2014
|
| Scott L. Nyberg co-investigator
|
Novel Biomaterials for Liver Tissue Engineering
|
National Science Foundation
|
09/2012 - 08/2013
|
| Scott L. Nyberg co-investigator
|
Extension Study to the Multicenter, Open-Label, Randomized, Controlled Study CRAD001H2304 to Evaluate the Long-Term Efficacy and Safety of Concentration-Controlled Everolimus in Liver Transplant Recipients
|
Novartis
|
07/2010 - 06/2012
|
|
Scott L. Nyberg principal investigator
|
A Novel Individualized Approach to the Correction of Human Metabolic Disorders of the Liver: Proof-of-Concept Studies
|
A Marriott Award in Individualized Medicine
|
07/2010 - 06/2012
|
|
Scott L. Nyberg co-investigator
|
Cognitive and Driving Performance in Idiopathic REM Sleep Behavior Disorder and Normal Controls
|
A Scholarly Opportunity Award — Mayo Clinic
|
12/2010 - 11/2012
|
| Scott L. Nyberg principal investigator & program director
|
Immunogenicity of a Xenogeneic Bioartificial Liver
|
National Institute of Diabetes and Digestive and Kidney Diseases
|
04/1999 - 03/2005
|
| Scott L. Nyberg principal investigator & program director
|
Xenogeneic Bioartificial Liver
|
National Institute of Diabetes and Digestive and Kidney Diseases
|
07/2006 - 06/2010
|
| Scott L. Nyberg co-investigator
|
Investigation of Tissue Level Expression and Secretion of Matrix Metalloproteinase 2 and 9 (Gelatinases) in a Porcine Polytetrafluoroethylene Graft Model of Venous Stenoses
|
Cardiovascular and Interventional Radiology Research and Educational Foundation
|
10/2000 - 11/2006
|
| Scott L. Nyberg principal investigator
|
A Pilot Study of Synthetic ECM/Basement Membrane on Gene Expression and Biochemical Function of Rat Hepatocytes in Vitro
|
Donaldson Company
|
10/2005 - 02/2008
|
| Scott L. Nyberg principal investigator
|
Hepatic Tissue Research Registry: Brief 1
|
Asterand
|
01/2007 - 12/2008
|
| Scott L. Nyberg co-investigator
|
Study of the Antiviral Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus Infection
|
Bristol-Myers Squibb — Pharmaceutical
|
09/2007 - 08/2010
|
|
Scott L. Nyberg co-investigator
|
A Phase II Randomized, Multicenter, Active Comparator-Controlled Trial to Evaluate the Safety and Efficacy of Coadministration of CP-690,550 and Mycophenolate Mofetil/Mycophenolate Sodium in De Novo Kidney Allograft Recipients
|
Pfizer Inc.
|
10/2007 - 09/2009
|
| Scott L. Nyberg co-investigator
|
A Phase II, Open-Label, Multicenter, Prospective, Conversion Study in Stable Liver Transplant Patients to Compare the Pharmacokinetics of LCP-Tacro Tablets Once-a-Day to Prograf Capsules Twice-a-Day
|
Life Cycle Pharma
|
01/2008 - 12/2008
|
| Scott L. Nyberg co-investigator
|
A Phase II, Open-Label, Multicenter, Randomized Trial to Demonstrate the Pharmacokinetics of LCP-Tacro Tablets Once Daily and Prograf Capsules Twice Daily in Adult De Novo Liver Transplant Patients
|
Life Cycle Pharma (LCP-Tacro 2018)
|
12/2008 - 11/2010
|
| Scott L. Nyberg principal investigator & program director
|
Hepatopig: A Model for Liver Cirrhosis, Hepatocellular Carcinoma and for Repopulation of the Liver With Transplanted Human Hepatocytes
|
Yecuris Corp.
|
04/2010 - 03/2011
|
| Scott L. Nyberg principal investigator & program director
|
An Improved Bioartificial Liver for Extended Therapy
|
A Discovery Translation Award From Mayo Clinic
|
07/2007 - 06/2009
|
| Scott L. Nyberg principal investigator & program director
|
Feasibility Study of Fetal Transplantation and Immune Tolerization in Pigs
|
Small Grants Program — Mayo Clinic
|
08/2009 - 08/2010
|
| Scott L. Nyberg principal investigator & program director
|
Role of Toll-Like Receptor 4 in the Systemic Inflammatory Response Syndrome of Acute Liver Failure
|
Small Grants Program — Mayo Clinic
|
09/2010 - 08/2011
|
|
|
|
|